Mechanically, we found that enhanced H3K18la leads to enhanced binding on the promoter region of Rela and NfκB1, thereby potentiating NFκB signaling and ultimately promoting SASP components IL-6 and IL-8, which dramatically impact brain aging and AD pathology. Here, IL6 is linked to Alzheimer disease.